Clinical trial
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced…
NCT00287911 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00287911 |
|---|---|
| Title | Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer |
| Official title | A Phase I Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, topotecan hydrochloride, brachytherapy, radiation therapy |
| Enrollment | 18 |
| Start date | Feb 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Feb 7, 2006 |
| Last update posted | Dec 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: